Halozyme Therapeutics, Inc. (HALO)
70.98
-1.06
(-1.47%)
USD |
NASDAQ |
Feb 20, 16:00
70.96
-0.02
(-0.03%)
After-Hours: 20:00
Halozyme Therapeutics Market Cap : 8.347B for Feb. 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Johnson & Johnson | 584.38B |
| Merck & Co., Inc. | 303.45B |
| Skye Bioscience, Inc. | 25.05M |
| AIM ImmunoTech, Inc. | 3.574M |
| Stryker Corp. | 145.51B |
Market Cap Related Metrics
| PE Ratio | 28.49 |
| PS Ratio | 6.236 |
| Price to Book Value | 171.00 |
| Price to Free Cash Flow | 13.51 |
| Price | 70.98 |
| Earnings Yield | 3.51% |
| Operating PE Ratio | 10.67 |
| Normalized PE Ratio | 15.46 |